This article emphasizes the importance of testing baroreceptor and cardiopulmonary
receptor control of circulation during angiotensin-converting enzyme (ACE) inhibitor …

Arterial blood pressure, heart rate and the response of these hemodynamic parameters to
exogenous norepinephrine were investigated in healthy volunteers (daily sodium intake of …

Objective: In essential hypertension, captopril attenuates forearm vasoconstriction reflexly
induced by deactivation of cardiopulmonary and arterial baroreceptors, thus exerting a …

Removal of the facilitating effect of angiotensin II on sympathetic cardiovascular influences
may enhance the antihypertensive effect of angiotensin converting enzyme (ACE) inhibitors …

Background. Both baroreflex sensitivity and flow‐mediated vasodilator function have been
recognized to have prognostic significance in cardiovascular diseases. Long‐term …

Introduction: Angiotensin II has both central nervous system and peripheral effects on
autonomic function. Ramipril is among the more lipophilic angiotensin converting enzyme …

The present experiments investigate whether the absence of tachycardia during lowering of
blood pressure (BP) with an angiotensin-converting enzyme inhibitor (CEI) in salt-depleted …

Background Human studies have shown that the blood pressure lowering effects of
angiotensin converting enzyme inhibitors are accompanied by a reduction in plasma …

We examined baroreflex function and plasma angiotensin II (Ang II) before and after the
treatment with an angiotensin converting enzyme inhibitor (ACEI) in eight inpatients with …

Captopril was given to 15 unselected patients with essential hypertension (WHO II) at a dose
range of 300 to 600 mg/day. Hemodynamic indexes (thermodilution) as well as levels of …